SOT recipients can develop either primary or secondary (reactivation) CMV infection and disease. Primary in- fection occurs when a CMV-seronegative (R-) individual receives an allograft from a CMV-seropositive donor (D+) ( 23). CMV-seronegative recipients lack pre-existing CMV-specific humoral and cell-mediated immunity and,
If you want to change selection, open document below and click on "Move attachment"
pdf
owner:
memeyrie - (no access) - CMV ASM.pdf, p2
Summary
status | not read | | reprioritisations | |
---|
last reprioritisation on | | | suggested re-reading day | |
---|
started reading on | | | finished reading on | |
---|
Details